| Article

| Article

| Article

According to estimates from the Centers for Disease Control and Prevention,  29.1 million people (close to 10% of the US population) have diabetes and 30% to 50% of them eventually develop diabetic peripheral neuropathy, often with pain. Neuropathic pain due to diabetes is a commonly encountered...

| Article

Through the lens of medical expert testimony and case examples, attendees will learn core areas of risk mitigation with a focus on making electronic medical records and paper charting work for the practitioner to demonstrate prescribing in the usual course of professional practice. Overdose—a small...

| Article

There is much controversy around many aspects of pain treatment, and compelling arguments have focused on both sides of the fence regarding appropriate opioid use and prescribing, legalization of marijuana, and the safety of cox-2 inhibitors. In all  3 cases, there are issues associated with strong...

| Article

Despite high prevalence and seemingly continuous attention, the clinical challenges associated with assessing, treating, and managing patients with chronic pain continue to persist. Many different forces are at play and responsible for this frequently frustrating situation and, as is often the case...

| Article

| Article

| Article

Breakfast will be served.

Sponsored by Teva Pharmaceuticals.

| Article

Breakfast will be served.

Sponsored by Teva Pharmaceuticals.

Subscribe to PAINWeekEnd

Sign-Up